ArticleCardio-oncology (London, England)2026

Long-term outcomes of prophylactic cardioprotection in early-stage breast cancer patients on non-anthracycline anti-HER2 therapy.

Thomas Q McClelland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.